The UK Public want the NHS to be the controlling body in Covid-19 contact-tracing app – says new research

20-May-2020 8:55 AM EDT, by University of Warwick

Newswise — The public have massive trust in the NHS, who should have control and access to data in the Covid-19 contact-tracing app, according to new research by researchers in WMG at the University of Warwick, and at the University of Birmingham.

Carsten Maple, Principal Investigator of the NCSC-EPSRC Academic Centre of Excellence in Cyber Security Research at the University of Warwick who led the research said:

"With all of the possible design choices for a contact-tracing app, many commentators and experts have argued which approach is in the best interests of the public. For example, some have argued that centralised apps create privacy invasions that are unacceptable; others have argued that to be effective the apps should be centralised. However, as yet, the opinions of the public have not been gathered and so we have undertaken a significant survey to elicit their thoughts. We have examined how important privacy is to them and how willing they are to engage and share information."

Dr Rebecca McDonald, lecturer in experimental economics from the University of Birmingham said:

"The first encouraging results of our study are that only 9.6% of the public always chose to opt-out of using the contact tracing apps we described to them. We asked people to express a direct preference between controlling the pandemic or preserving privacy, and we found that over half (57.4%) of participants favoured prioritising controlling the pandemic over privacy, contrasting with around a fifth (20.1%) favouring protecting privacy over controlling the pandemic."

However the most powerful and important result from the survey was the contrasting degrees to which participants trust different agencies or individuals with their data, even when anonymised. The group least trusted to be given access to this data was other app users but by far the most trusted group or organisation was the NHS.

Professor Carsten Maple in WMG at the University of Warwick said:

"It is clear that the NHS enjoyed overwhelming trust in terms of access to personal data collected by such apps, even when anonymised. Surprisingly, respondents’ choices suggest they would be most concerned about the decentralised approach that protects from Government access to information and instead shares information among other app users. The results indicate that users want a centralised approach, like the one currently being adopted by NHSX.

"Our research clearly shows that the public is broadly supportive of the use of a COVID-19 contact tracing app and would download it in significant numbers, providing the app providers listen to their wishes on who should have access to their data. The NHS is by far the most trusted gatekeeper for that data."

The table below shows in percentage terms how much more willing people are to use an app when their data is shared with different organisations (as in a centralised approach), compared to when it is shared with other app users (as in a decentralised approach).

 

NHS

70.5%

Researchers

53.4%

National Government

18.9%

Local Government

13.0%

 The research highlights that people have a strong desire to understand the way a contact tracing app would work, and many respondents said they would need control over what data is shared about them, and who it is shared with, before they would be willing to download the app. Since widespread uptake is needed for the app to be effective, addressing these potential barriers has to be at the heart of any large-scale roll out of the contact tracing app. The appetite is there, but the public need transparency in order to trust, download, and use the app.

The research also found that public would also have concerns about linking proximity data to other data sources. (They were particularly concerned about the linkage of their shopping location from credit/debit cards data. Some also had concerns about practical things like the impact on their phone’s battery life, or the amount of data the app might need to use.

The researchers surveyed 2,171 members of the UK general population in a nationally representative sample and have published that research today in a paper entitled “Speak for Yourself! Attitudes to contact tracing applications in the context of COVID 19: results from a nationally representative survey of the UK population” at: https://github.com/carstenmaple/SpeakForYourself.NB the paper has not been peer reviewed but has been published now due to the urgency of the issues it examines.



Filters close

Showing results

110 of 6112
Newswise: New Study Details Enzyme That Allows Coronavirus to Resist Antiviral Medications
Released: 3-Aug-2021 12:20 PM EDT
New Study Details Enzyme That Allows Coronavirus to Resist Antiviral Medications
Iowa State University

A new Iowa State University study details the structure of a critical enzyme present in SARS-CoV-2, the coronavirus that causes COVID-19. This enzyme removes nucleoside antiviral medications from the virus’s RNA, rendering many treatments ineffective. Scientists could use data uncovered in the new study to find ways to inhibit the enzyme, possibly leading to more effective treatments.

Released: 2-Aug-2021 6:05 PM EDT
Rethinking Remdesivir
University of California San Diego Health

UC San Diego researchers modify remdesivir, creating oral version that can be taken earlier in COVID-19 diagnoses. In cell and animal studies, revised drug proved effective and safe.

Newswise: Researchers from Hackensack Meridian University Medical Center and Colleagues Develop New Model to Help Clinicians Predict Risk of Death in Patients Hospitalized with COVID-19
Released: 2-Aug-2021 4:25 PM EDT
Researchers from Hackensack Meridian University Medical Center and Colleagues Develop New Model to Help Clinicians Predict Risk of Death in Patients Hospitalized with COVID-19
Hackensack Meridian Health

New COVID-19 40-day mortality risk model, published in The Public Library of Science ONE, has potential for use in patient treatment planning, comparisons of therapeutic strategies, and public-health preparations.

Released: 2-Aug-2021 4:05 PM EDT
Town Hall on Effectiveness of COVID-19 Vaccination in Immunosuppressed Patients Hosted by the American College of Rheumatology
American College of Rheumatology (ACR)

How effective COVID-19 vaccines have been in immunosuppressed and rheumatic disease patients remains an incompletely answered question. The American College of Rheumatology (ACR) has organized an expert panel to share what we are learning from real-world data and answer questions.

Released: 2-Aug-2021 2:00 PM EDT
CDC withdrawing its request for emergency use authorization for its COVID-19 PCR diagnostic test does not mean the test failed
Newswise

Social media is now rife with claims about why the CDC is withdrawing its request for emergency use authorization for its COVID-19 PCR diagnostic test after December 2021.

Newswise: Existing Drug Is Shown to Inhibit Virus That Causes COVID-19
Released: 2-Aug-2021 1:30 PM EDT
Existing Drug Is Shown to Inhibit Virus That Causes COVID-19
Argonne National Laboratory

Scientists using the Advanced Photon Source have discovered that a drug used to fight tumors in animals might be effective against many types of coronaviruses, including SARS-CoV-2.

Released: 2-Aug-2021 11:25 AM EDT
Award-Winning Journalist and CDC Principal Investigator to Serve as ACR Convergence 2021 Keynote Speaker
American College of Rheumatology (ACR)

Convergence 2021, the annual meeting of the American College of Rheumatology (ACR), returns to a virtual meeting platform Nov. 1 - 10. This year’s meeting will include presentations from over 320 clinicians, researchers and health experts, including this year’s keynote speaker, Dr. Seema Yasmin.

Newswise: COVID-19: Small Sign of Hope as Vaccinations Rise
Released: 2-Aug-2021 10:45 AM EDT
COVID-19: Small Sign of Hope as Vaccinations Rise
Cedars-Sinai

As COVID-19 cases spike in Los Angeles and throughout the Golden State, driven by the spread of the delta variant among unvaccinated residents, there may be a small sign of hope: More people are finally getting their shot.

Newswise: New Evidence Shows the COVID-19 Delta Variant Rapidly Rising
Released: 31-Jul-2021 10:05 AM EDT
New Evidence Shows the COVID-19 Delta Variant Rapidly Rising
University of Miami Health System, Miller School of Medicine

The University’s coronavirus sequencing effort uncovered that there are several variants present in its patient population, but Delta is chief among them and easily transmitted. And its presence is likely triggering a local surge in the infectious disease. University of Miami researchers and physicians are seeing firsthand how rapidly the Delta variant of COVID-19 is spreading through the local population.


Showing results

110 of 6112

close
1.47179